RecruitingPhase 4NCT06468202
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Studying Preeclampsia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ohio State University
- Principal Investigator
- Maged Costantine, MD, MBAOhio State University
- Intervention
- Aspirin 81 mg(drug)
- Enrollment
- 10742 target
- Eligibility
- 14-35 years · FEMALE
- Timeline
- 2024 – 2030
Study locations (16)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Cedars Sinai Medical Center, Los Angeles, California, United States
- University of California, San Francisco, San Francisco, California, United States
- Northwestern University, Chicago, Illinois, United States
- University of Mississippi, Jackson, Mississippi, United States
- University of New Mexico, Albuquerque, New Mexico, United States
- Columbia University, New York, New York, United States
- University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States
- The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus, Ohio, United States
- University of Pittsburg Magee, Pittsburgh, Pennsylvania, United States
- Brown University, Providence, Rhode Island, United States
- University of Texas, Houston, Houston, Texas, United States
- University of Utah, Salt Lake City, Utah, United States
- Inova HealthSystem, Falls Church, Virginia, United States
- Eastern Virginia Medical School - Old Dominion University, Norfolk, Virginia, United States
- +1 more locations on ClinicalTrials.gov
Collaborators
Patient-Centered Outcomes Research Institute · Northwestern University · Preeclampsia Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06468202 on ClinicalTrials.govOther trials for Preeclampsia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07199283The PreEclampsia Postpartum Prevention TrialKarolinska Institutet
- RECRUITINGNCT06427408Longitudinal Study of Gene Expression in the Human Placenta During First-trimester and Full-term Pregnancy at the Single Cell LevelAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT07443345Incidence of Postoperative Diaphragmatic Dysfunction in Pregnant Women With PreeclampsiaCairo University
- RECRUITINGNANCT07209254Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum HypertensionJennifer Lewey, MD, MPH
- RECRUITINGNCT07513558Preeclampsia: Origin, Characteristics and Effects on Mother and BabyMedical University of Graz
- RECRUITINGPHASE2NCT06333652Ravulizumab in Pregnancies Complicated by Severe Hypertensive DisordersMayo Clinic
- RECRUITINGNCT06464159New Therapeutic Strategy Against PreeclampsiaAssistance Publique - Hôpitaux de Paris
- RECRUITINGNANCT06953115Vagal Stimulation Therapy and PreeclampsiaFundación Internacional René Mey